“All of this happening … is really a major inflection point”

Interview with Greg Bailey, CEO of Juvenscence Dr. Greg Bailey is the CEO of Juvenescence, a UK biotech company that has secured $110m to commercialise research into aging and age-related diseases. Bailey co-founded the company alongside Jim Mellon and Dr Declan Doogan and hopes to harness his many years of medical and financial expertise to drive the Longevity revolution. Longevity.Technology sat down with him for an exclusive interview. Longevity.Technology: How would you define Longevity? Greg Bailey: There are two definitions to Longevity in human aging. The easiest one is lifespan, which is, of course, the age you live to be.…

We’d love to share more of this article with you.

You can login to your account or sign-up to one of our subscription plans to continue reading...